Literature DB >> 31298402

Research on cardioprotective effect of irbesartan in rats with myocardial ischemia-reperfusion injury through MAPK-ERK signaling pathway.

G-D Ren1, Y -Y Cui, W-L Li, F-F Li, X-Y Han.   

Abstract

OBJECTIVE: The aim of this study was to explore whether the mechanism of Irbesartan (IRB) in the treatment of rats with myocardial ischemia-reperfusion injury (MIRI) was related to the mitogen-activated protein kinase (MAPK)-extracellular signal-regulated kinase (ERK) signaling pathway.
MATERIALS AND METHODS: The rat model of MIRI was first successfully established. All rats were randomly divided into 5 groups, including the Sham group (sham operation control group, ligation only), Model group (MIRI rat model group), IRB12.5 group [low-dose IRB (12.5 mg/kg/d) group], IRB50.0 group [medium-dose IRB (50.0 mg/kg/d) group] and IRB200.0 group [high-dose IRB (200.0 mg/kg/d) group]. After treatment of IRB in MIRI rats, the activities of four myocardial enzyme indexes, including creatine kinase-MB (CK-MB), aspartate aminotransferase (AST), lactate dehydrogenase (LDH) and cardiac troponin T (cTnT), were detected via enzyme-linked immunosorbent assay (ELISA). The effect of IRB on myocardial apoptosis in MIRI rats was detected via Annexin V-fluorescein isothiocyanate/Propidium Iodide (FITC/PI) double staining. Meanwhile, the messenger ribonucleic acid (mRNA) levels of ERK, B-cell lymphoma-2 (Bcl-2) and Bcl-2 associated X protein (Bax) in myocardial cells after treatment of IRB were detected via Reverse Transcription-Polymerase Chain Reaction (RT-PCR). Furthermore, the protein levels of ERK and p-ERK were detected via Western blotting.
RESULTS: Different concentrations of IRB could protect myocardium from MIRI. IRB at doses of 50.0 mg/kg/d and 200.0 mg/kg/d could significantly downregulate myocardial enzyme indexes in MIRI (p<0.01). Meanwhile, both the doses could markedly inhibit myocardial apoptosis in MIRI rat model by regulating the expressions of apoptosis-related genes (Bcl-2 and Bax) (p<0.01), eventually improving myocardial pathological damage. At the same time, it could also significantly decrease the mRNA and protein levels of ERK in the MAPK-ERK signaling pathway (p<0.05).
CONCLUSIONS: The cardioprotective mechanism of IRB in MIRI rats may be related to the inhibition of the activation of the MAPK-ERK signaling pathway.

Entities:  

Year:  2019        PMID: 31298402     DOI: 10.26355/eurrev_201906_18218

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  8 in total

1.  Angiotensin II receptor blocker irbesartan attenuates sleep apnea-induced cardiac apoptosis and enhances cardiac survival and Sirtuin 1 upregulation.

Authors:  Pei-Ying Pai; Yi-Yuan Lin; Chih-Yang Huang; Shin-Da Lee; Shao-Hong Yu; Ching-Yuang Lin; Yi-Fan Liou; Xu-Bo Wu; James K S Wong
Journal:  Sleep Breath       Date:  2021-10-09       Impact factor: 2.655

2.  L-Borneol 7-O-[β-D-Apiofuranosyl-(1→6)]-β-D-Glucopyranoside Alleviates Myocardial Ischemia-Reperfusion Injury in Rats and Hypoxic/Reoxygenated Injured Myocardial Cells via Regulating the PI3K/AKT/mTOR Signaling Pathway.

Authors:  Ziyi Tong; Gaowen Li; Chengxiao Su; Liyan Zhou; Ling Zhang; Qun Chen; Qing Xia
Journal:  J Immunol Res       Date:  2022-05-12       Impact factor: 4.493

3.  Long non‑coding RNA GAS5 regulates myocardial ischemia‑reperfusion injury through the PI3K/AKT apoptosis pathway by sponging miR‑532‑5p.

Authors:  Yang Han; Nan Wu; Fei Xia; Shuang Liu; Dalin Jia
Journal:  Int J Mol Med       Date:  2020-01-20       Impact factor: 4.101

4.  Protective role of emodin in rats with post-myocardial infarction heart failure and influence on extracellular signal-regulated kinase pathway.

Authors:  Jinfeng Liu; Liang Ning
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

5.  Long non-coding RNA growth arrest specific transcript 5 acting as a sponge of MicroRNA-188-5p to regulate SMAD family member 2 expression promotes myocardial ischemia-reperfusion injury.

Authors:  Jin Xu; Dong Yu; Xiaolu Bai; Peng Zhang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

6.  CD14 Involvement in Third-degree Skin Burn-induced Myocardial Injury via the MAPK Signaling Pathway.

Authors:  Zhensen Zhu; Ben Zou; Songying Gao; Dongmei Zhang; Jingdong Guo; Bo Chen; Haixin Hou; Xiongxiang Zhu
Journal:  Cell Biochem Biophys       Date:  2021-07-23       Impact factor: 2.194

7.  D-Limonene mitigate myocardial injury in rats through MAPK/ERK/NF-κB pathway inhibition.

Authors:  Nancy Safwat Younis
Journal:  Korean J Physiol Pharmacol       Date:  2020-05-01       Impact factor: 2.016

8.  PPARγ Plays an Important Role in Acute Hepatic Ischemia-Reperfusion Injury via AMPK/mTOR Pathway.

Authors:  Liwei Wu; Qiang Yu; Ping Cheng; Chuanyong Guo
Journal:  PPAR Res       Date:  2021-07-03       Impact factor: 4.964

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.